Breaking News, Collaborations & Alliances

ProBioGen Partners with ModeX to Accelerate COVID-19 Antibody Development

Collaboration encompasses a full spectrum of services, including cell line development, process optimization & large-scale GMP production.

Author Image

By: Charlie Sternberg

Associate Editor

ProBioGen, a contract development and manufacturing organization (CDMO) known for its solutions in cell engineering and bioprocessing excellence, has entered a collaboration with ModeX Therapeutics, an OPKO Health company.   ModeX has signed a Master Services Agreement with ProBioGen to accelerate the development and production of clinical material for their multi-specific COVID-19 antibody.   This strategic fee-for-service collaboration encompasses a full spectrum of services, including adv...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters